Physician profile
Johnny Wu
NPI 1457477853
$9,827.94
in general payments reported to CMS, 2019-2025
6 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.98 · 2020: $61.08 · 2021: $42.78 · 2022: $387 · 2023: $1,478 · 2024: $7,545 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,990 · Travel and Lodging: $2,035 · Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,990.00 |
| Travel and Lodging | $2,035.07 |
| Food and Beverage | $1,227.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $8,968.79 | 2019-2025 | Epclusa |
| Braeburn INC. | $239.50 | 2023-2024 | Brixadi |
| Indivior INC. | $210.24 | 2022-2024 | Sublocade |
| Abbott Laboratories | $179.34 | 2022 | |
| Amgen INC. | $125.00 | 2025 | Uplizna |
| Heartflow, INC. | $105.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.